FDA accused of scant monitoring of deceptive food labeling (Nutraingredients.com)
7/31/2006 - The nation s Food and Drug Administration (FDA) has been accused of misleading Congress by ignoring the enforcement of key regulatory provisions intended to provide accurate food labeling.

Names & notes: FDA grants Intracel study special protocol assessment (Gazette.Net)
Intracel, a Frederick biotechnology company developing patient-specific cancer immunotherapies, has been granted a special protocol assessment by the FDA for the execution of a Phase III clinical trial of OncoVAX, a tumor-specific whole cell immunotherapy designed to attack cancer cells in stage II colon carcinoma.